Skip to main content
. 2019 Feb 5;16(4):834–841. doi: 10.5114/aoms.2019.82723

Table I.

Characteristics of patients with UA, DA or without anemia

Characteristics Whole population
(n = 981)
Unexplained anemiae
(n = 48)
Defined anemiac,d
(n = 121)
No anemia groupa,b
(n = 812)
P-value
Female, n (%) 594 (61) 27 (56) 52 (63) 504 (62) 0.09
Age, mean ± SD [years] 70.8 ±8.45 75.9 ±9.2 74.7 ±9.3 69.8 ±8.0 < 0.0001
Hb, mean ± SD [g/dl] 13.47 ±1.79 11.2 ±1.2 10.2 ±1.6 14.09 ±1.06 < 0.0001
WBC, mean ± SD [× 109/l] 6.94 ±2.77 7.08 ±3.29 7.93 ±5.74 6.78 ±1.90 0.63
PLT, mean ± SD [× 109/l] 234.6 ±71.6 231.7 ±82.3 269.9 ±117.9 229.5 ±59.4 0.01
eGFR, , mean ± SD [ml/min/1.73 m2] 81.4 ±22.9 74.4 ±26.5 70.7 ±28.1 83.4 ±21.3 < 0.0001
CRP, mean ± SD [mg/l] 24.3 ±51.8 25.7 ±80.6 42.9 ±60.0 6.2 ±14.6 < 0.0001
Number of comorbidities median (range) 2 (0–12) 4 (1–7) 4 (0–9) 2 (0–8) < 0.0001
Number of hospitalizations median (range) 0 (0–12) 1 (0–8) 2 (0–12) 0 (0–11) < 0.0001
Barthel scale, mean ± SD 85 ±12.3 80 ±14.9 80 ±16.2 85 ±8.4 < 0.0001
Death, n (%) 40 (4) 5 (10) 16 (13) 19 (2) < 0.0001
a

A significantly greater value in the NA group than the UA group and the NA group than the DA group for the following parameters: Hb, eGFR and Barthel scale scores. bA significantly lower value in the NA group than the UA group and the NA group than the DA group for the following parameters: number of hospitalizations, number of comorbidities in patients. cA significantly greater value in the DA group than the NA group for the following parameters: PLT, CRP, age and deaths. dA significantly greater value in the DA group than the UA group for the following parameters: CRP and PLT. eA significantly greater value in the UA group than the NA group for the following parameters: age and deaths. CRP – C reactive protein, DA – defined anemia, eGFR – estimated glomerular filtration rate, Hb – hemoglobin, NA – no anemia, PLT – platelet count, UA – unexplained anemia, WBC – white blood cell count. A p-value less than 0.05 was considered statistically significant.